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Abstract The aim of this study was to compare the
findings of the cervical flexion–rotation test (FRT) between
subjects with probable cervicogenic headache (CGH),
migraine without aura (Migraine), and multiple headache
forms (MHF). An additional aim was to identify the
diagnostic accuracy of the FRT in CGH evaluation. Sixty
subjects were evaluated: 20 with CGH, 20 with Migraine,
and 20 with MHF. Subject and headache symptoms were
evaluated by questionnaire. A single-blind examiner con-
ducted the FRT, reporting the test state (positive or nega-
tive) before measuring range of motion using a goniometer.
The average range of unilateral rotation to the most
restricted side was 25, 42 and 35 for groups CGH,
Migraine and MHF, respectively. The difference between
groups was significant (P \ 0.001). Range of rotation was
significantly reduced in the CGH group when compared to
groups Migraine (P \ 0.001) and MHF (P = 0.001), with
an additional smaller significant difference between groups
Migraine and MHF (P = 0.039). A receiver operating
curve revealed that an experienced examiner using the FRT
was able to make the correct diagnosis 85% of the time
(P \ 0.001), with a positive cut-off value of 30. Multi-
variate regression analysis revealed that 44% of the vari-
ance in FRT range of motion was explained by the
presence of two variables: neck movement or positions
provoke headache, and neck symptoms precede headache,
but not by other factors associated with migraine. These
findings provide further evidence supporting the clinical
utility of the FRT in CGH evaluation.
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Introduction
Headache is among the most prevalent of pain disorders,
affecting the majority of the population [1], disturbing both
quality of life and work productivity [2, 3].
Migraine is one of the common primary headaches [4], the
underlying mechanisms of which are poorly understood but
are believed to involve abnormal brain function [5] including
functional cortical hyperexcitability arising from among other
things, reduced inhibition from the cortex [6]. In contrast
cervicogenic headache (CGH) is a subgroup of secondary
headache, stemming from a disorder of the cervical spine [7].
The mechanisms underlying CGH [8] are based on the con-
cept of convergence of afferent information from musculo-
skeletal structures in the upper three cervical segments with
trigeminal afferents in the trigeminocervical nucleus (TCN).
Hence input via sensory afferents from any of the upper cer-
vical nerve roots is mistakenly perceived as pain in the head.
Differentiating different headache forms is principally
based on the history and presenting symptoms, together with
the clinical physical examination [9]. For example, migraine
without aura is the most common sub-type of migraine, lasting
a fixed time period of 24–72 h. Diagnostic characteristics
include unilateral location, pulsating quality, moderate to
severe intensity, aggravated by activity, and associated with
nausea, photophobia or phonophobia [10]. However, a num-
ber of these features are also associated with CGH [11] as is
the presence of neck pain [12]. As a result, one of the common
diagnostic challenges in headache evaluation is to distinguish
CGH from migraine [13]. Indeed studies have shown that an
incorrect headache diagnosis may occur in more than 50% of
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cases [14]. Since migraine and CGH have very different
underlying pathological mechanisms, it is very important to
correctly classify the headache disorder so that treatment can
be directed appropriately. For example, physiotherapy has
been found to be effective for CGH [15, 16] but not for
migraine [17].
Up to 74% of individuals with frequent intermittent head-
ache and migraine report accompanying neck pain [12, 13,
18], but this does not necessarily indicate dysfunction in the
cervical spine. Associated neck symptoms during headache
may simply suggest spread and referral of pain via trigemino–
cervical interaction, resulting in hyperalgesia and allodynia
[12]. Consequently, physical examination of the neck is a
critical component of CGH diagnosis [19], particularly where
subjective characteristics are not clearly indicative of any one
headache form or where multiple headache forms (MHF)
co-exist. As CGH predominantly arises from musculoskeletal
dysfunction in the upper three cervical segments [8], physical
examination of the upper cervical spine is particularly
important. Recently it has been shown that collectively, cer-
vical movement impairment, in association with palpable
upper cervical joint dysfunction and impairment in cranio-
cervical muscle control, has 100% sensitivity and 94% spec-
ificity to identify CGH from migraine [20].
The flexion–rotation test (FRT) has shown promise as a
valid and reliable test of upper cervical movement
impairment associated with CGH [21–24]. Movement
during this test occurs predominantly at C1/2, as a result of
maximally flexing the cervical spine, pre-emptively con-
straining movement at all other levels [25]. We have pre-
viously demonstrated that the FRT has high levels of
accuracy in CGH diagnosis [24], but the comparison group
in that study were asymptomatic controls and a relatively
‘‘pure’’ form of migraine with aura, which is easily defined.
To date no studies have investigated whether the FRT is
reduced in mobility in subjects with Migraine or in subjects
with subjective features suggesting MHF. If subjects with
CGH have significantly greater impairment on the FRT
than subjects with Migraine or with MHF, then this further
validates the utility of the FRT in CGH evaluation.
The main purpose of this study was to compare FRT
mobility between three groups: Migraine, CGH, and MHF.
Secondary purposes were to examine the diagnostic accu-
racy of the FRT in CGH diagnosis and to determine the
most significant predictors of range of motion during
the FRT. This knowledge has the potential to improve the
clinical utility of the FRT.
Methods
A single-blind comparative measurement study design was
used to determine whether range recorded during the FRT
and examiner interpretation of the FRT differs between
subjects with MHF and those with Migraine and CGH. The
Curtin University Human Research Ethics Committee
granted approval for this study, which was conducted in
accordance with the ethical standards laid down in the 1964
Declaration of Helsinki. Subjects gave written informed
consent prior to the study commencement and were able to
withdraw from the study at any time.
Subjects
Sample size estimate was based on data collected from
previous studies [24, 26]. Based on a single measurement
of the FRT, with a standard deviation of 11 for range of
motion, and a calculated effect size of 0.4 [27, 28], a priori
power analysis determined that a total sample size of 60
subjects (20 in each group) was required to obtain a sta-
tistical power of 0.80 with alpha set at 0.05.
Subjects were recruited in a manner of convenience
through advertisements placed in local newspapers and
through Curtin University website. Volunteers were
screened for eligibility into three groups: Migraine, CGH
or MHF. For all subjects headache frequency was required
to be at least once per week for more than the previous
3 months. Migraine was defined according to the IHS
diagnostic criteria [10], CGH was defined according to the
criteria proposed by Sjaastad [11] and further evaluated by
Antonaci [29], with the exception of diagnostic anaesthetic
blocks. These criteria were intermittent, side dominant
headache of moderate intensity, without side shift. The
headache was required to be preceded by ipsilateral neck
pain and precipitated or aggravated by neck movement
or posture, thereby fulfilling 5 of 7 criteria outlined by
Antonaci [29] as indicative of ‘‘probable’’ CGH. Subjects
in either the migraine or CGH group were excluded if they
also met the IHS criteria for other headache forms. Sub-
jects who reported two or more distinct forms of headache
were defined as MHF. In all three groups subjects were
excluded if they were unable to tolerate the FRT (none
were excluded in this way) or if they had received physical
treatment to their neck from a physiotherapist or other
health professional in the previous 4 weeks. In addition, to
account for the potential for a concurrent cervical spine
disorder in the Migraine group, subjects were excluded if
they had interictal episodes of neck pain or a known cer-
vical spine disorder.
Respondents to advertisements (n = 115) were screened
by either telephone or face-to-face interview with 55
rejected, according to the inclusion and exclusion criteria.
Accordingly 20 subjects with Migraine (12 female, mean
age 30 years, range 18–59, SD 6.5), 20 subjects with CGH
(11 female, mean age 35 years, range 18–61, SD 10.9) and
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20 subjects with MHF (15 female, mean age 33 years,
range 20–63, SD 9.4) were recruited. Headache symptoms
and other characteristics are shown in Table 1.
Procedures
Entry-level eligibility was based on inclusion and exclu-
sion criteria and assessed by a separate researcher, an
experienced specialist musculoskeletal physiotherapist.
Subsequently all subjects completed a questionnaire to
obtain an index of headache severity (0–100, with 100
being maximum severity) [30]. This index is based on a
composite score of headache frequency, duration, and
intensity with equal weight given to each element. Previ-
ously this index has been shown to have high levels of
reliability with ICC(2,1) of 0.92 [30]. Additional demo-
graphic details, including subject and headache character-
istics were also assessed by questionnaire. These
characteristics included: dominant side of headache,
headache of pulsating quality, nausea, photophobia or
phonophobia, anti-migraine medication helps, forward
trunk bend increases pain, neck movement or positions
provoke headache, headache aggravated by exertion, and
neck symptoms precede headache.
One specialist musculoskeletal physiotherapist experi-
enced in using the FRT, who was unaware of the subject’s
clinical presentation, assessed all subjects. An experienced
examiner was utilized, as the purpose of this study was not
to investigate reliability but to investigate differences in
impairment of range of motion during the FRT in subjects
with different headache forms. We have previously estab-
lished high levels of intra-rater reliability for range of
motion measured by an experienced examiner. Intra-class
correlation coefficients were reported as 0.95 (95% CI
0.90–0.98) [23]. Furthermore, examiner interpretation of
the FRT has been shown to be consistent over time with
Kappa of 0.92 [23].
The FRT consisted of pre-positioning the cervical spine
in maximal end range flexion followed by passive rotation
of the head to the left and the right, with the subject relaxed
in supine. End of range was determined either by firm
resistance encountered by the therapist or the subject
reporting the onset of pain, whichever came first. The
intention was to measure range of motion irrespective of
cause of limitation, in the least provocative manner, to
prevent potential exacerbation of symptoms. The examiner
made a visual estimate of the range of rotation to determine
whether the FRT was positive or negative, and then
reported the test state and the positive direction if any.
Table 1 Characteristics of the subjects in groups Migraine, CGH and MHF
Variable Headache group
CGH (n = 20) Migraine (n = 20) MHF (n = 20)
History of headache (years)
Mean (SD) 4.8 (2.8) 9.1 (4.8) 5.7 (3.9)
Range 0.5–11.0 4.0–20.0 0.5–14
Index of headache severity (/100)
Mean (SD) 56.3 (10.8) 54.1 (14.1) 47.9 (11.4)
Range 35.0–81.0 31.3–81.6 31.3–71.0
Dominant side of headache
Left 8 4 5
Right 12 7 11
Bilateral 0 9 4
Positive flexion–rotation test 14 5 8
Pulsating headache 4 12 7
Photophobia 5 16 8
Phonophobia 4 15 9
Nausea 5 16 9
Neck positions/movement provoke headache 20 3 8
Neck symptoms precede headache 17 4 10
Anti-migraine medication helps 1 13 5
Forward bend increases headache 6 13 9
Exertion increases headache 6 16 14
Migraine migraine without aura, CGH cervicogenic headache, MHF multiple headache forms
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A positive test was defined where the visually estimated
range was reduced by more than 10 from the anticipated
normal range of 44 [21, 24]. Subsequently the FRT pro-
cedure was repeated and mobility determined by using a
cervical range of motion device (CROM). The CROM is a
floating compass [Plastimo Airguide Inc (Compasses),
1110 Lake Cook Road, Buffalo Groove, Illinois, 60089]
attached to the apex of the head by Velcro straps [21, 24].
All subjects were tested on one occasion on a headache-
free day to negate the influence of headache at the time of
testing [23]. All 11 subjects complained of headache on the
day of testing and were required to return on a symptom-
free day.
Statistical analysis
Statistical analysis was carried out using SPSS V17.0.
(SPSS Inc., 444 N. Michigan Avenue, Chicago, Illinois,
60611). Alpha was set at 0.05 for each analysis. One-way
ANOVA and planned orthogonal comparisons were used to
determine differences in FRT mobility between groups.
The sensitivity and specificity of the FRT were analysed
using cross tabulation and were determined with a receiver
operating characteristic (ROC) curve. To calculate the
sensitivity and specificity the subjects with Migraine and
MHF were combined and then compared to the subjects
with CGH. The frequencies used to calculate sensitivity
and specificity are given in Table 1. The dichotomous
variables used to determine the sensitivity and specificity
were the therapist’s assessment of whether the FRT was
positive (10 visually estimated limitation of range) and
whether the subject had CGH or not. The ROC curve was
created using the FRT range of motion values. Finally,
forward stepwise multiple linear regression analysis (for-
ward stepwise; P to enter \0.05, P to remove [0.1) was
used to determine the relationship between subject and
headache characteristics and range of motion during the
FRT.
Findings
Subject recruitment occurred from January to December
2008. All 60 subjects completed this study. The demo-
graphic and headache characteristics of the study sample
are presented in Table 1.
All underlying assumptions for repeated measure
ANOVA were met. The range of rotation to the most
restricted side was significantly lower in the CGH group
when compared to the Migraine and MHF groups
[P B 0.001; mean (SD) range 25.2 (11.1), 41.8 (5.1) and
35.1 (8.0), respectively] (Fig. 1). There was also a
significant but smaller difference in range between the
Migraine and MHF groups (P = 0.039) (Fig. 1).
The examiner interpreted the FRT as positive in 70% of
subjects (14/20) from the CGH group and 30% of subjects
(12/40) from the combined groups Migraine and MHF.
Consequently for CGH diagnosis the FRT had sensitivity
of 0.7 (95% CI 0.46–0.87), specificity of 0.7 (95% CI 0.53–
0.83), positive predictive value of 0.54 (95% CI 0.34–
0.74), negative predictive value of 0.82 (95% CI
0.65–0.93), positive likelihood ratio of 2.33 (95% CI 1.34–
4.06) and negative likelihood ratio of 0.43 (95% CI 0.21–
0.85). Examination of sensitivity and specificity data
plotted on a ROC curve (Fig. 2) revealed that an experi-
enced clinician should be able to correctly differentiate a
patient with CGH from one from the Migraine or MHF
groups 85% of the time (P \ 0.001). Additionally, coor-
dinates on the ROC curve indicated that, in this sample, the
test value that provides the highest sensitivity and the
lowest 1-specificity was 30. In other words range of 30,
measured using a compass goniometer, represents the cut-
off score for a positive test.
When variables ‘‘neck movement or positions provoke
headache’’ and ‘‘neck symptoms precede headache’’ and
other variables (gender, age, history of headache, dominant
side of headache, anti-migraine medication helps, forward
bend increases headache, presence of photophobia or
phonophobia, nausea or headache of pulsating quality)
were entered into forward stepwise multiple linear regres-
sion analysis with range of motion towards the most
restricted side during the FRT as the dependent variable,
‘‘neck movement or positions provoke headache’’ and
‘‘neck symptoms precede headache’’ were the most sig-
nificant predictors of range of motion (Table 2). These
Fig. 1 The mean range of motion and 95% confidence interval of
unilateral cervical rotation in maximal flexion to the most restricted
side for each subject group
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variables accounted for 44% of the variance in FRT range
of motion [F(2,59) = 24.5, P \ 0.001], with neck move-
ment or positions provoke headache as the most significant
predictor accounting for 41% of the variance. Once these
two variables had been entered into the model, none of the
remaining independent variables made sufficient additional
contribution to the model to meet the entry criterion.
Discussion
This is the first reported study to compare FRT range of
motion deficits in subjects with CGH, Migraine and MHF.
We found a clinically significant difference in range of
motion between the different headache groups. Range was
most restricted in subjects with CGH (25), significantly
greater impairment than either group’s Migraine (42) or
MHF (35). Similarly, subjects with MHF had significantly
lesser range than those subjects with Migraine. The data for
range of motion measured during the FRT are similar to
those reported in previous studies using the CROM device
in subjects with CGH [26, 31]. Mean range of rotation
towards the most restricted side was 25 in the current
study and 22 and 26 in previous reports [26, 31]. In the
present study an asymptomatic group was not included, but
compared to previous studies range recorded in the
Migraine group was marginally less than the reported
normal range of 44–45 to each side [21, 32].
Our results for mean range of motion for subjects with
Migraine concur with a previous report of mean range of
39 for subjects with migraine with aura [24]. It would
appear that the presence of an aura has minimal effect on
range of motion during the FRT. As range of motion for
subjects with Migraine was also consistent with asymp-
tomatic controls this might indicate that, in general terms,
cervical movement dysfunction is not a pre-requisite for
migraine either with or without aura. This observation is
consistent with a previous study investigating active range
of motion. Subjects with Migraine had range consistent
with asymptomatic controls, which was significantly
greater than range in subjects with CGH [19, 33]. In
another study of episodic migraine, only range of right
rotation was significantly reduced by 8 when compared to
healthy controls [34]. Interestingly in cases of unilateral
pain, limitation was not associated with the symptomatic
side of migraine [34], which is different from CGH where
the limitation of movement is predominantly to the
symptomatic side, particularly when evaluated by the FRT.
Further evidence of a lack of cervical movement impair-
ment in Migraine was demonstrated by a recent systematic
review, although the reviewers were critical of the meth-
odological quality of many of the reviewed studies [35].
Migraine headache is experienced in the regions inner-
vated by the cutaneous afferents of the trigeminal and C2
and C3 nerves, all of which have input into the TCN [35].
Sensitization of the TCN is postulated as central to the
pathophysiology of CGH, migraine and other headache
forms and may explain why some patients with headache
complain of neck pain [12], and demonstrate limitation of
cervical range of motion, in the absence of cervical mus-
culoskeletal disease [36]. Furthermore sensitization of the
TCN may also increase neck muscle tone through
increased motor efferent activity, with consequent effect of
limiting range of motion of the neck [37]. If TCN sensi-
tization were the cause of headache then limitation in range
is unlikely to be related to a specific side or level of cer-
vical motion segment dysfunction, and the FRT is unlikely
to be significantly restricted. We found only 5/20 subjects
with migraine with a positive FRT, indicating a lack of
Fig. 2 The diagnostic accuracy of the cervical flexion–rotation test.
The area under the curve is 0.85 (P \ 0.001, CI 0.75, 0.95)
Table 2 Forward stepwise multiple linear regression analysis with b,
standard error, P, and adjusted R2 values presented: predictive vari-
ables for range of motion towards the most restricted side during the










Neck symptoms precede headache 5.51 2.54 0.04
Adjusted R2 = 0.44, R2 change for ‘‘Neck positions/movement pro-
voke headache’’ = 0.41, R2 change for ‘‘Neck symptoms precede
headache’’ = 0.04. Variables entered forward stepwise
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segmental joint restriction in the majority of migraine
sufferers. Consistent with this and as previously stated no
association was found between the side of migraine head-
ache and direction of movement limitation [34]. Thus for a
patient with headache, associated neck pain and minor
limitation of cervical range of motion does not necessarily
indicate a cervical contributing factor. Further physical
examination tests are required in that patient to confirm the
presence of CGH. It is the combination of limitation of
cervical movement together with evidence of deep neck
flexor dysfunction and pain on palpation of the upper
cervical spine that confirms the presence of CGH with a
high degree of certainty [20].
Previously it has been shown that the FRT has good
diagnostic accuracy to identify subjects with CGH from
subjects with migraine with aura and asymptomatic con-
trols [24, 26]. In the study by Ogince et al. [24] subjects
with CGH were compared with control subjects, whereas in
this study the comparison was with subjects with Migraine
or MHF. This difference in comparison groups would also
explain the slightly lower cut-off value in the present study
when compared with earlier studies (30 against 32) [26].
This has implications for clinical practice where diagnosis
of CGH might rely on a number of features including
presenting symptoms as well as physical examination [22].
In patients who have subjective features that do not fit into
a specific headache category (or who have evidence of
MHF) then the physical examination might be more
important and a lower cut-off score is necessary on the
FRT to be confident of a diagnosis of CGH. In patients with
relatively pure form of CGH, clearly defined by the pre-
senting symptoms, then a higher cut-off score might be
adequate.
It is important to recognise that the FRT is a relatively
isolated test of movement impairment of the C1/2 motion
segment [25], and may not adequately test other motion
segments or indeed other upper cervical structures poten-
tially contributing to a patient’s CGH. This might explain
the negative test finding in 6/20 subjects with CGH, where
cervical motion segments or structures other than C1/2 may
have been the cause of headache. Hence it is important not
to rule out the potential for CGH in patients negative on the
FRT.
We found that variables forward bend increases head-
ache, anti-migraine medication helps, photophobia, pho-
nophobia, nausea, pulsating headache, exertion increases
headache, history of headache, gender, and age were not
associated with range of motion towards the restricted side
during the FRT. The only factors associated with range of
motion were neck movement or positions provoke head-
ache, and neck symptoms precede headache. The variable
neck position or movement provoke headache accounts for
41% of the variance (adjusted R2 = 0.41). The inclusion of
the variable neck pain precedes headache results in an
additional 4% of the variance (R2 = 0.4). This result is not
surprising when considering these two associated factors
are determinants of CGH and that apart from age, gender
and history of headache, the non-associated factors are
common complaints of migraine, but rarely reported by
subjects with CGH [38]. Previously we have also shown
that three headache features (headache severity, frequency
and duration), either separately or combined into an index
[30], also influence range of motion during the FRT in
subjects with CGH [31]. In addition we have shown that
the presence of pain at the time of testing also influences
range of motion [23]. Hence the FRT appears to be asso-
ciated with a number of different factors including the
presence and severity of headache as well as the factors
suggesting cervical spine dysfunction.
The interpretation and generalization of these results
needs to be cautioned by a number of potential limitations.
Firstly, one experienced examiner tested all subjects. Sec-
ondly a diagnosis of ‘‘probable’’ CGH was only possible as
diagnostic injection block procedures were not available,
hence some subjects may have been misclassified. Finally
14/20 subjects with CGH were positive on the FRT, which
may indicate that subjects were misclassified as CGH or
did not have headache arising from C1/2.
Conclusions
Range of motion towards the most restricted side during
the FRT is significantly reduced in subjects with CGH
when compared to subjects with Migraine or MHF. Fur-
thermore, the FRT has good sensitivity and specificity in
the diagnosis of CGH and the cut-off value for a positive
test is range of motion less than 30 for differentiation
between these headache groups. Subjective features char-
acteristic of Migraine are not associated with FRT range of
motion but features consistent with CGH are. These find-
ings provide further evidence supporting the clinical utility
of the FRT.
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